DrugPatentWatch Database Preview
VAZCULEP Drug Profile
» See Plans and Pricing
Which patents cover Vazculep, and when can generic versions of Vazculep launch?
Vazculep is a drug marketed by Avadel Legacy and is included in one NDA.
The generic ingredient in VAZCULEP is phenylephrine hydrochloride. There are twenty-one drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Vazculep
A generic version of VAZCULEP was approved as phenylephrine hydrochloride by WEST WARD PHARM CORP on December 20th, 2012.
Summary for VAZCULEP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 64 |
| Patent Applications: | 1,612 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VAZCULEP |
| DailyMed Link: | VAZCULEP at DailyMed |
Pharmacology for VAZCULEP
| Drug Class | alpha-1 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha1-Agonists |
US Patents and Regulatory Information for VAZCULEP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avadel Legacy | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-001 | Jun 27, 2014 | AP1 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Avadel Legacy | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-002 | Jun 27, 2014 | AP1 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Avadel Legacy | VAZCULEP | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 204300-003 | Jun 27, 2014 | AP1 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
